US Broker Ratings

Regeneron Pharmaceuticals (REGN): Investor Outlook Reveals 34% Potential Upside Amidst a Diverse Product Portfolio

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is a formidable player in the biotechnology industry, with a significant presence in the healthcare sector. Headquartered in Tarrytown, New York, Regeneron has carved out..

Doximity, Inc. (DOCS) Stock Analysis: Navigating Healthcare’s Digital Frontier with 2% Upside Potential

Doximity, Inc. (NYSE: DOCS), a leading digital platform for healthcare professionals, is capturing investor attention with its robust growth trajectory and burgeoning market presence in the health information services sector...

Haleon plc (HLN) Stock Report: Exploring a 20% Potential Upside with Strong Analyst Ratings

Haleon plc (HLN), a stalwart in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, is turning heads with its potential 20.39% upside, according to analyst ratings...

Blueprint Medicines Corporation (BPMC) Stock Analysis: Navigating the Upside with a Robust 55.50% Revenue Growth

Blueprint Medicines Corporation (NASDAQ: BPMC), a prominent player in the biotechnology sector, is catching the attention of investors with its impressive revenue growth of 55.50%. As a precision therapy company,..

Medpace Holdings, Inc. (MEDP) Stock Analysis: High ROE and Strategic Growth in Healthcare Research

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a pivotal player in the healthcare sector, specifically within the diagnostics and research industry. With a substantial market capitalization of $8.96 billion, this..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with 35.80% Upside Potential

In the rapidly evolving biotechnology sector, argenx SE (NASDAQ: ARGX) emerges as a prominent player, currently commanding a market capitalization of $34.95 billion. Headquartered in the Netherlands, this commercial-stage biopharmaceutical..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 24.58% Potential Upside

HealthEquity, Inc. (NASDAQ: HQY), a significant player in the healthcare sector, is capturing investor attention with its potential upside of 24.58%. As a leader in health information services, HealthEquity provides..

Revvity, Inc. (RVTY) Stock Analysis: Navigating a 33% Potential Upside in the Healthcare Sector

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, has emerged as a significant investment opportunity with a market capitalization of $10.99 billion. This diagnostics and research company,..

Gilead Sciences, Inc. (GILD) Stock Analysis: Evaluating a 7.9% Upside Amidst Robust Dividends

Gilead Sciences, Inc. (NASDAQ: GILD) stands as a prominent player in the healthcare sector, specifically within the drug manufacturers industry, demonstrating a steadfast commitment to addressing unmet medical needs across..

Fresenius Medical Care AG (FMS) Stock Analysis: Uncovering an 18% Upside Potential

Fresenius Medical Care AG (NYSE: FMS) stands as a significant player in the healthcare sector, particularly within the medical care facilities industry. With a robust market capitalization of $15.91 billion,..

Bristol-Myers Squibb (BMY) Stock Analysis: Evaluating a 20.56% Upside Potential

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, stands as a significant player in the general drug manufacturing industry. Headquartered in Princeton, New Jersey, this biopharmaceutical giant..

Natera, Inc. (NTRA) Stock Analysis: Unpacking a 38.79% Potential Upside in the Diagnostics Powerhouse

Natera, Inc. (NASDAQ: NTRA) has emerged as a compelling player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $18.97 billion, this Austin-based..

Exelixis, Inc. (EXEL) Stock Analysis: Evaluating the 30.6% Revenue Growth and Future Prospects

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, is making waves with its impressive 30.6% revenue growth, capturing the attention of healthcare investors. Specializing in oncology, the..

Thermo Fisher Scientific Inc. (TMO) Stock Analysis: Uncovering a 33.72% Potential Upside Amid Strong Buy Ratings

Thermo Fisher Scientific Inc. (NYSE: TMO), a dominant player in the healthcare sector, particularly in diagnostics and research, has captured the attention of investors with its robust market presence and..

The Cooper Companies, Inc. (COO) Stock Analysis: Examining a 28% Potential Upside in the Healthcare Sector

The Cooper Companies, Inc. (NYSE: COO), a formidable player in the healthcare sector, particularly within the medical instruments and supplies industry, presents a compelling opportunity for individual investors. With a..

Eli Lilly and Company (LLY) Stock Analysis: Robust Growth and 23% Potential Upside Captivate Investors

Eli Lilly and Company (LLY) stands as a powerhouse in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $692.79 billion, the company has established..

Insulet Corporation (PODD) Stock Analysis: A Promising 18% Upside Potential in the Medical Device Sector

Insulet Corporation (NASDAQ: PODD), a leading player in the medical devices industry, is garnering attention from investors eager to tap into the booming healthcare sector. With a market capitalization of..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Growth Potential in the Healthcare Sector

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, continues to capture investor interest with its strategic positioning in the global pharmaceutical industry. Headquartered in Hyderabad,..

Encompass Health Corporation (EHC): Analyst Ratings Signal 19.61% Upside Potential

Encompass Health Corporation (NYSE: EHC) stands out within the healthcare sector, particularly in the medical care facilities industry. With its roots dating back to 1984 under the name HealthSouth Corporation,..

McKesson Corporation (MCK) Stock Analysis: Analyzing Its 6.87% Potential Upside Amidst Strong Revenue Growth

For investors eyeing opportunities in the healthcare sector, McKesson Corporation (NYSE: MCK), a stalwart in the medical distribution industry, presents a compelling case. With a market capitalization of $88.66 billion,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds